Literature DB >> 8223880

Peptide variants reveal how antibodies recognize major histocompatibility complex class I.

K A Hogquist1, A G Grandea, M J Bevan.   

Abstract

The T cell receptor (TcR) on CD8+ T lymphocytes recognizes a complex which consists of a major histocompatibility complex (MHC) heavy chain, beta 2-microglobulin (beta 2M), and peptide on the surface of antigen-presenting cells. Mutational analyses have suggested that the TcR recognizes both the alpha 1 and alpha 2 domains of the heavy chain as well as the peptide. In light of this, it is of interest to know to what extent the heavy chain domains take on distinct conformations when bound to individual peptides. It has recently been shown that antibodies which recognize the Kb MHC complex are sensitive to which peptides are bound in the groove. We have extended this analysis to include eight Kb-specific antibodies, seven of which are peptide sensitive. These antibodies, all of which are allo-antibodies, recognize Kb-bearing cells which, it is now appreciated, have a highly heterogeneous mix of self peptides presented in their grooves. We show that these self peptides also can affect antibody binding. It has been suggested that peptides alter the conformation of the alpha 1 and alpha 2 domains of the heavy chain and that this in turn affects the recognition of Kb by antibody. An alternative hypothesis is that solvent-exposed peptide side chains may prevent the antibody from binding the complex. Using a panel of 128 single-amino acid variants of a Kb-binding antigenic peptide from ovalbumin we show that for most Kb-specific antibodies, the second idea is more likely. Those variants which prevent antibody binding are at solvent exposed positions, and in general, the bulkier the side chain, the greater the inhibition of antibody binding. However, in the case of two antibodies, 100.30 and 34.4.20, the peptide residues which affect antibody recognition are buried, suggesting that these antibodies see an alternate conformation of the peptide/MHC complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223880     DOI: 10.1002/eji.1830231145

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. II. Cross-reaction between a monoclonal antibody and two alpha beta T cell receptors.

Authors:  D Rognan; J Engberg; A Stryhn; P S Andersen; S Buus
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.

Authors:  Judith Racape; Francine Connan; Johan Hoebeke; Jeannine Choppin; Jean-Gérard Guillet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

Review 3.  Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin.

Authors:  J C Solheim; J R Cook; T H Hansen
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 4.  Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system.

Authors:  K D Smith; Z B Kurago; C T Lutz
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.

Authors:  D H Fremont; E A Stura; M Matsumura; P A Peterson; I A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.

Authors:  F Huang; E Hermann; J Wang; X K Cheng; W C Tsai; J Wen; J G Kuipers; H Kellner; B Ackermann; G Roth; K M Williams; D K Yu; R B Raybourne
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

7.  Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.

Authors:  L A Salvucci; R H Bonneau; S S Tevethia
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.

Authors:  R Dyall; D H Fremont; S C Jameson; J Nikolić-Zugić
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

9.  Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.

Authors:  W Chen; S Khilko; J Fecondo; D H Margulies; J McCluskey
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  Differential ability of isolated H-2 Kb subsets to serve as TCR ligands for allo-specific CTL clones: potential role for N-linked glycosylation.

Authors:  L Shen; K P Kane
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.